5/6/2021  6:02:56 PM Chg. -2.2600 Volume Bid7:58:12 PM Ask7:49:00 PM Market Capitalization Dividend Y. P/E Ratio
64.1600EUR -3.40% 4,304
Turnover: 276,318.6200
-Bid Size: - -Ask Size: - 19.54 bill.EUR 2.09% 16.21

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.

Management board & Supervisory board

Rice Powell
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Dr. Olaf Schermeier, Frank Maddux, MD, Harry de Wit, Kent Wanzek, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon, William P. Johnston

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 45.94%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 19 | 5/6/2021 Interim Report 1st Quarter/3 Months
CW 21 | 5/20/2021 General Shareholder Meeting
CW 31 | 7/30/2021 Interim Report 2nd Quarter/6 Months
CW 45 | 11/2/2021 Interim Report 3rd Quarter/9 Months

Main Shareholders

Fresenius SE & Co. KGaA
Thornburg Investment Management Inc.
Harris Associates L.P.
BlackRock, Inc.
Artisan Partners Asset Management Inc.
FIL Limited
Norges Bank